{"id":"W4399119041","doi":"10.1016/s2468-1253(24)00095-5","title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","year":2024,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"AstraZeneca United States","keywords":"Gemcitabine; Durvalumab; Interim analysis; Cisplatin; Placebo; Topaz; Interim; Medicine; Internal medicine; Oncology; Biliary tract cancer; Cancer; Clinical trial; Chemotherapy; Biology; Pathology; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002165998,0.001117012,0.002594043,0.0003260172,0.0002478829,0.000941207,0.0007855854,0.001155351,0.00475068],"category_scores_gemma":[0.002269723,0.0005311167,0.003116515,0.0004187807,0.0005475928,0.001160053,0.0005099693,0.0027504,0.0005881094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001008569,"about_ca_system_score_gemma":0.0005617306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001610154,"about_ca_topic_score_gemma":0.005376017,"domain_scores_codex":[0.9991643,0.0004881317,0.00006331153,0.0001033314,0.00006603354,0.0001148517],"domain_scores_gemma":[0.9989273,0.0003926467,0.0003189897,0.00009483935,0.00007065817,0.0001955278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9584294,0.0008490018,0.001925212,0.001794031,0.005775533,0.00003996314,0.00006421201,0.0003482795,0.001399094,0.0001104084,0.001656113,0.02760876],"study_design_scores_gemma":[0.9329258,0.03993774,0.01437338,0.0002418524,0.009107888,0.00008773617,0.00008801138,0.0002766348,0.0004503568,0.000341669,0.002131871,0.00003698796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9570112,0.03392267,0.0004586124,0.001195962,0.0008660129,0.0009262953,0.003112154,0.00009595149,0.002411191],"genre_scores_gemma":[0.9838563,0.008747761,0.0006999987,0.001477588,0.0003870242,0.0008781098,0.002126397,0.00002864119,0.00179805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00475068,"threshold_uncertainty_score":0.01589257,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04131311166689571,"score_gpt":0.3340527491027465,"score_spread":0.2927396374358508,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}